Cephalexin recalls
The FDA has published 20 recalls involving Cephalexin since 2014. The latest was reported on 18 Jun 2025. Most were for potency & assay. Ascend Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 20 since 2014
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 8 latest 18 Jun 2025
Recalls per month, last 24 months click a bar for that month
Severity split
Class I 0 0% Class II 15 75% Class III 5 25%
Why cephalexin is recalled
Ongoing cephalexin recalls 8 active
Reported Class Recall Company Reason Where 18 Jun 2025 Drug CLASS II Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 18 Jun 2025 Drug CLASS II Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 125mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 250mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 250mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 250mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide
All cephalexin recalls, newest first 20 total
Reported Class Recall Company Reason Where 18 Jun 2025 Drug CLASS II Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 18 Jun 2025 Drug CLASS II Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 125mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 250mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 250mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 250mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 12 Jun 2024 Drug CLASS III Cephalexin for Oral Suspension, USP, 125mg recalled Cephalexin Bryant Ranch Prepack Other Nationwide 5 May 2021 Drug CLASS II Cephalexin for Oral Suspension, Generic for Keflex recalled Cephalexin Preferred Pharmaceuticals Potency & Assay CA 24 Feb 2021 Drug CLASS II Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 24 Feb 2021 Drug CLASS II Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 13 Jan 2021 Drug CLASS II Cephalexin for Oral Suspension, USP, 125 mg recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 6 Jan 2021 Drug CLASS II Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 6 Jan 2021 Drug CLASS II Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled Cephalexin Ascend Laboratories Potency & Assay Nationwide 16 Sep 2020 Drug CLASS II Cephalexin for Oral Suspension, USP 250 mg recalled Cephalexin Teva Pharmaceuticals USA Potency & Assay Nationwide 16 Sep 2020 Drug CLASS II Cephalexin for Oral Suspension, USP 125 mg recalled Cephalexin Teva Pharmaceuticals USA Manufacturing (CGMP) Deviations Nationwide 16 Sep 2020 Drug CLASS II Cephalexin for Oral Suspension, USP 250 mg recalled Cephalexin Teva Pharmaceuticals USA Manufacturing (CGMP) Deviations Nationwide 6 Feb 2019 Drug CLASS II Cephalexin for Oral Suspension USP 250mg recalled Cephalexin Lupin Pharmaceuticals Foreign Material Nationwide 12 Nov 2014 Drug CLASS II Cephalexin Monohydrate Capsules,USP, 500 mg recalled Physicians Total Care Manufacturing (CGMP) Deviations GA, MO 13 Aug 2014 Drug CLASS II Cephalexin Capsules, USP, 500 mg recalled by Caraco Pharmaceutical Caraco Pharmaceutical Laboratories Manufacturing (CGMP) Deviations Nationwide 13 Aug 2014 Drug CLASS II Cephalexin Capsules, USP, 250 mg recalled by Caraco Pharmaceutical Caraco Pharmaceutical Laboratories Manufacturing (CGMP) Deviations Nationwide
Should you stop taking Cephalexin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.